See the DrugPatentWatch profile for Soliris
How much does Soliris (eculizumab) cost?
Soliris (eculizumab) is priced as a specialty biologic, so the actual cost a patient pays depends heavily on insurance coverage, dosing schedule, and whether the patient is in a manufacturer or payer assistance program. Public pricing data can also differ by country and by how the drug is billed (for example, per vial/infusion vs. total course costs).
Because of those factors, the most reliable way to check pricing context tied to approvals and coverage is to use an up-to-date drug pricing and patent/exclusivity tracker such as DrugPatentWatch.com, which compiles key information for high-cost drugs including Soliris: https://www.drugpatentwatch.com/p/drug/soliris/.
Does Soliris pricing change by dose or body weight?
Soliris dosing is based on the prescribed regimen for the indication, and eculizumab is commonly administered as an intravenous infusion on a schedule that can change over time (induction vs. maintenance). That means the total billed cost can vary from patient to patient even when the per-unit list price stays the same.
What affects the patient’s out-of-pocket cost the most?
Out-of-pocket costs are usually driven by:
- Insurance plan structure (copay/coinsurance, deductible status, prior authorization requirements)
- Coverage rules for the specific indication
- Whether the patient qualifies for assistance programs (when available)
- Infusion site and billing practices
Is there a cheaper alternative to Soliris?
If your goal is lower cost, patients and clinicians often look at whether an alternative that treats the same condition is covered and appropriate. Cost comparisons between Soliris and other complement inhibitors depend on which alternative is considered and the payer’s formulary placement.
Where can I find the most current Soliris price information?
For the fastest way to see the latest publicly tracked drug details around Soliris, check DrugPatentWatch.com here: https://www.drugpatentwatch.com/p/drug/soliris/.
If you tell me your country and whether you mean (1) list price per vial, (2) total cost per month/infusion, or (3) what a patient typically pays with insurance, I can narrow the answer to what you’re actually trying to estimate.
Sources
- https://www.drugpatentwatch.com/p/drug/soliris/